SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Treatment effect modification due to comorbidity: Individual participant data meta-analyses of 120 randomised controlled trials
5 references·1 citing·29 second hop
Treatment effect modification due to comorbidity: Individual participant data meta-analyses of 120 randomised controlled trials (2023)Treatment effect modification due to como…Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analyses (2020)Development of the Instrument…No improvement in the reporting of clinical trial subgroup effects in high-impact general medical journals (2016)No improvement in the reporti…Evidence Synthesis for Decision Making 1 (2013)Evidence Synthesis for Decisi…Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses (2010)Is a subgroup effect believab…Eligibility Criteria of Randomized Controlled Trials Published in High-Impact General Medical Journals (2007)Eligibility Criteria of Rando…Core GRADE 5: rating certainty of evidence—assessing indirectness (2025)Core GRADE 5: rating certaint…CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials (2010)Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force (2013)Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients (2015)Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force (2022)The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials (2001)The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized Trials (2001)External validity of randomised controlled trials: “To whom do the results of this trial apply?” (2005)Delivering affordable cancer care in high-income countries (2011)Best care at lower cost: the path to continuously learning health care in America (2014)ESMO Guidance for Reporting Oncology real-World evidence (GROW) (2023)The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration (2001)Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed (2002)Credibility of claims of subgroup effects in randomised controlled trials: systematic review (2012)Justification and reporting of subgroup analyses were lacking or inadequate in randomized controlled trials (2018)Adverse Events Reporting Quality of Randomized Controlled Trials of COVID-19 Vaccine Using the CONSORT Criteria for Reporting Harms: A Systematic Review (2022)Multi-disciplinary fairness considerations in machine learning for clinical trials (2022)What to add to nothing? Use and avoidance of continuity corrections in meta‐analysis of sparse data (2004)Checking consistency in mixed treatment comparison meta‐analysis (2010)Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial (2010)Network meta-analysis: a norm for comparative effectiveness? (2015)A systematic review of the clinical effectiveness and cost-effectiveness of pharmacological and psychological interventions for the management of obsessive–compulsive disorder in children/adolescents and adults (2016)Wasted research when systematic reviews fail to provide a complete and up-to-date evidence synthesis: the example of lung cancer (2016)Health Measurement Scales: A Practical Guide to Their Development and Use (1989)A revised tool for assessing risk of bias in randomized trials (2016)A Mobile Phone–Based Intervention to Reduce Mental Health Problems in Health Care Workers During the COVID-19 Pandemic (PsyCovidApp): Randomized Controlled Trial (2021)A guide and pragmatic considerations for applying GRADE to network meta-analysis (2023)GRADE guidance 36: updates to GRADE's approach to addressing inconsistency (2023)GRADE guidelines: 3. Rating the quality of evidence (2011)GRADE guidelines: 8. Rating the quality of evidence—indirectness (2011)
this work references cited by second hop

References

  • 2007Eligibility Criteria of Randomized Controlled Trials Published in High-Impact General Medical Journals1,056 cited
  • 2010Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses805 cited
  • 2020Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analyses749 cited
  • 2013Evidence Synthesis for Decision Making 1164 cited
  • 2016No improvement in the reporting of clinical trial subgroup effects in high-impact general medical journals41 cited

Cited by

  • 2025Core GRADE 5: rating certainty of evidence—assessing indirectness19 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work